A Study of ASP8273 in Subjects With Non-small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Mutations

NCT03082300 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
3
Enrollment
INDUSTRY
Sponsor class

Stopped Following recommendation by SOLAR Study IDMC, Astellas closed enrollment in ASP8273 studies.

Conditions

Interventions

Sponsor

Astellas Pharma Global Development, Inc.